[HTML][HTML] Clinical implications of BRAF mutation test in colorectal cancer

EN Mojarad, RK Farahani, MM Haghighi… - … and Hepatology from …, 2013 - ncbi.nlm.nih.gov
Abstract Knowledge about the clinical significance of V-Raf Murine Sarcoma Viral Oncogene
Homolog B1 (BRAF) mutations in colorectal cancer (CRC) is growing. BRAF encodes a …

Spatial-frequency dual-branch attention model for determining KRAS mutation status in colorectal cancer with T2-weighted MRI

Y Ma, J Wang, K Song, Y Qiang, X Jiao… - Computer Methods and …, 2021 - Elsevier
Abstract Background and Objective: Identifying the KRAS mutation status accurately in
medical images is very important for the diagnosis and treatment of colorectal cancer …

RAS/RAF/MAPK Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic Review

S Benmokhtar, A Laraqui, F Hilali… - Clinical Medicine …, 2024 - journals.sagepub.com
Background: This review article aims to investigate the prevalence and spectrum of rat
sarcoma (RAS) and V-Raf Murine Sarcoma Viral Oncogene Homolog B (BRAF) mutations …

Frequency of K-RAS and N-RAS gene mutations in colorectal cancers in southeastern Iran

M Naseri, A Sebzari, F Haghighi… - Asian Pacific Journal …, 2016 - journal.waocp.org
Background: K-RAS and N-RAS gene mutations cause resistance to treatment in patients
with colorectal cancer. Based on this, awareness of mutation of these genes is considered a …

Common KRAS and NRAS gene mutations in sporadic colorectal cancer in Northeastern Iranian patients

L Hamzehzadeh, F Khadangi, EG Karimiani… - Current Problems in …, 2018 - Elsevier
Objectives Mutation analysis of the Epidermal Growth Factor Receptor downstream has
been a main part of colorectal carcinoma evaluation. Large prospective clinical trials have …

[HTML][HTML] K-ras mutation in colorectal cancer, a report from Southern Iran

N Omidifar, B Geramizadeh, M Mirzai - Iranian journal of medical …, 2015 - ncbi.nlm.nih.gov
There are very few studies about K-ras mutations in colorectal cancer (CRC) from
developing countries such as Iran. It is therefore essential to conduct studies to learn about …

Prognostic value of BRAF and KRAS mutation in relation to colorectal cancer survival in Iranian patients: correlated to microsatellite instability

E Nazemalhosseini-Mojarad… - Journal of …, 2020 - Springer
Purpose To evaluate the prognostic role of BRAF and KRAS mutations after adjustment for
microsatellite instability (MSI) in Iranian colorectal cancer (CRC) patients. Methods BRAF …

Molecular Biomarkers of Colorectal Cancer: A review of published articles from Iran

B Geramizadeh - Iranian Journal of Colorectal …, 2015 - colorectalresearch.sums.ac.ir
Context Colorectal cancer is one of the most common cancers worldwide (the third most
common cancer in the world) and is especially more common in Western countries; …

[HTML][HTML] Polymorphism of SMAD7 gene (rs2337104) and risk of colorectal cancer in an Iranian population: a case-control study

Z Akbari, N Safari-Alighiarloo… - … and hepatology from …, 2014 - ncbi.nlm.nih.gov
Aim: The purpose of this study was to evaluate the influence of intronic polymorphism of the
SMAD7 (Mothers Against Decantaplegic Homolog 7) gene (rs2337104) on the risk of …

Correlation between microsatellite instability and RAS gene mutation and stage Ⅲ colorectal cancer

W Niu, G Wang, J Feng, Z Li, C Li… - Oncology …, 2019 - spandidos-publications.com
Correlation between RAS gene mutation and microsatellite instability (MSI) status in cancer
tissues and clinicopathological parameters of patients with stage Ⅲ colorectal cancer (CRC) …